Late Recurrence of Cholangiocarcinoma

Alejandro Calvo; Stella Pak; Nataly Torrejon

Loading...

Late Recurrence of Cholangiocarcinoma

;
;

African Journal of Biology and Medical Research

Vol. 1Issue 12018pp. 1–5Published 26 August 2018

1,912Views

596Downloads

Metrics

Share Link

𝕏

Cite this

Citation unavailable for this article.

Abstract:

Cholangiocarcinoma is associated with a poor prognosis usually due to advanced stage at the time of diagnosis and limited treatment options. In patients with localized disease, surgical resection of the malignant lesion remains the only potentially curative treatment. Duration of surveillance after tumor resection and adjuvant therapy remains controversial. Most oncologists will see patients periodically for up to 5 years. We present a case of a 71-year-old woman with recurrence of cholangiocarcinoma in the lung 11-years after curative resection. This case report suggests that prolonged surveillance beyond 5 years may be indicated for cholangiocarcinoma patients at high risk for recurrence after curative resection.

Keywords:8

Copyrights

Authors retain copyright in their articles and have unrestricted rights to reuse, republish, archive, share, and distribute their work after publication.
All articles are published open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, including for commercial purposes, provided appropriate credit is given to the original author(s) and source.

Loading…

Disclaimer/Publisher’s Note

The statements, opinions and data contained in this publication are solely those of the author(s) and contributor(s) and not of AB Journals or its editors. AB Journals remains neutral and accepts no responsibility for any injury or damage resulting from ideas, methods, instructions or products referred to in the content.

Copyrights

Authors retain copyright in their articles and have unrestricted rights to reuse, republish, archive, share, and distribute their work after publication.
All articles are published open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence, which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, including for commercial purposes, provided appropriate credit is given to the original author(s) and source.